Firms/companies
Now, you can buy a Nano on your credit card
06 Mar 2013
Xstrata’s profit plunges 37% in 2012
06 Mar 2013
JLR to invest £2.75 bn for eight models in 2013
06 Mar 2013
The company’s facility in the UK will produce a new generation of technologically-advanced, lightweight, low-emission four-cylinder diesel and petrol engines
TCS ranked world's 4th most valuable IT services brand
05 Mar 2013
TCS was the single largest contributor to the overall Tata brand and was ranked the world’s 39th most valuable brand by UK-based brand valuation firm Brand Finance Plc
TCS ranked world's 4th most valuable IT services brand
05 Mar 2013
TCS was the single largest contributor to the overall Tata brand and was ranked the world’s 39th most valuable brand by UK-based brand valuation firm Brand Finance Plc
Dow Chemicals wins $2.48 bn arbitration award over scrapped Kuwait JV
05 Mar 2013
In one of the several international deals that were aborted during the global recession, the Dow-Petrochemical Industries Co JV was scrapped less than a week before the deal was to become effective
OIL reports major oil find in Rajasthan
05 Mar 2013
Oil India expects crude output at the new discovery to be around 30,000 barrels per day
After Videocon, Anadarko puts 10 % stake in Mozambique gas field on the block
By By Ravi Kunder | 05 Mar 2013
Analysts believe the prime contenders for the prized stakes would be Royal Dutch Shell, Repsol, ExxonMobil, BP, and China’s Sinopec, which could prove to be the most aggressive bidder. By Ravi Kunder
After Videocon, Anadarko puts 10 % stake in Mozambique gas field on the block
By By Ravi Kunder | 05 Mar 2013
Analysts believe the prime contenders for the prized stakes would be Royal Dutch Shell, Repsol, ExxonMobil, BP, and China’s Sinopec, which could prove to be the most aggressive bidder. By Ravi Kunder
Jaguar Land Rover to invest another £150 mn at new engine plant
05 Mar 2013
Tata Motors' luxury car arm is building the new plant, currently in the first phase of construction, to produce engines for Jaguars and Land Rovers
Bayer loses cancer drug patent case
04 Mar 2013
The ruling ensures that cancer patients would be able to buy generic Nexavar at Rs8,800 for a month’s dose against Rs2,80,000 for Bayer’s branded Nexavar